• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thyroid oncology.

作者信息

M Bugalho Maria João, Wohllk Nelson, Hoff Ana O, Cabanillas Maria E

机构信息

Serviço de Endocrinologia, Instituto Português de Oncologia, 1099-023 Lisboa, Portugal.

出版信息

J Thyroid Res. 2011;2011:467570. doi: 10.4061/2011/467570. Epub 2011 Oct 9.

DOI:10.4061/2011/467570
PMID:22007337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3191810/
Abstract
摘要

相似文献

1
Thyroid oncology.甲状腺肿瘤学。
J Thyroid Res. 2011;2011:467570. doi: 10.4061/2011/467570. Epub 2011 Oct 9.
2
The Bethesda system for reporting thyroid cytopathology in Colombia: Correlation with histopathological diagnoses in oncology and non-oncology institutions.哥伦比亚甲状腺细胞病理学报告的贝塞斯达系统：与肿瘤学和非肿瘤学机构组织病理学诊断的相关性。
J Cytol. 2015 Jan-Mar;32(1):12-6. doi: 10.4103/0970-9371.155224.
3
Relationship between TSH and free thyroxine in outpatient cancer patient population.门诊癌症患者人群中 TSH 与游离甲状腺素的关系。
Endocrine. 2023 Nov;82(2):319-325. doi: 10.1007/s12020-023-03399-3. Epub 2023 Jun 8.
4
Adequacy and Effectiveness of Watson For Oncology in the Treatment of Thyroid Carcinoma.沃森肿瘤解决方案在甲状腺癌治疗中的充分性和有效性。
Front Endocrinol (Lausanne). 2021 Mar 3;12:585364. doi: 10.3389/fendo.2021.585364. eCollection 2021.
5
Parvovirus B19 detection analysis in thyroid tissue paired samples: an observational study from a tertiary surgical oncology department.甲状腺组织配对样本中细小病毒 B19 的检测分析：来自三级外科肿瘤学系的观察性研究。
J BUON. 2021 May-Jun;26(3):1016-1021.
6
Microscopic positive surgical margins in thyroid carcinoma: a proposal for thyroid oncology teams.甲状腺癌的显微镜下阳性手术切缘：甲状腺肿瘤团队的建议。
Langenbecks Arch Surg. 2021 May;406(3):563-569. doi: 10.1007/s00423-021-02095-y. Epub 2021 Feb 8.
7
Evolution of anaplastic thyroid cancer management: perspectives in the era of precision oncology.间变性甲状腺癌治疗的演变：精准肿瘤学时代的观点
Ther Adv Endocrinol Metab. 2021 Oct 29;12:20420188211054692. doi: 10.1177/20420188211054692. eCollection 2021.
8
Cytomorphological Categorization of Thyroid Lesions according to The Bethesda System for Reporting Thyroid Cytology and Correlation with their Histological Outcome: An Indian Oncology Centre Experience.根据甲状腺细胞病理学报告的贝塞斯达系统对甲状腺病变进行细胞形态学分类及其与组织学结果的相关性：一家印度肿瘤中心的经验
J Cytol. 2022 Jan-Mar;39(1):44-50. doi: 10.4103/JOC.JOC_79_20. Epub 2022 Jan 31.
9
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.美国头颈部学会内分泌外科分会和国际甲状腺肿瘤学会共识声明：甲状腺癌的基因突变检测——定义晚期甲状腺癌及其靶向治疗。
Head Neck. 2022 Jun;44(6):1277-1300. doi: 10.1002/hed.27025. Epub 2022 Mar 11.
10
Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group.临床试验中的相关性研究：国际甲状腺肿瘤学组的立场声明
J Clin Endocrinol Metab. 2015 Dec;100(12):4387-95. doi: 10.1210/jc.2015-2818. Epub 2015 Sep 29.

本文引用的文献

1
An individualized approach to the child with thyroid cancer.
Expert Rev Endocrinol Metab. 2011 Jan;6(1):85-92. doi: 10.1586/eem.10.66.
2
Incidental papillary microcarcinoma of the thyroid--further evidence of a very low malignant potential: a retrospective clinicopathologic study with up to 30 years of follow-up.
Ann Surg Oncol. 2011 Dec;18 Suppl 3:S306; author reply S307. doi: 10.1245/s10434-011-1865-2. Epub 2011 Jun 28.
3
Thyroid nodule guidelines: agreement, disagreement and need for future research.甲状腺结节指南：一致性、分歧和未来研究的需要。
Nat Rev Endocrinol. 2011 Jun;7(6):354-61. doi: 10.1038/nrendo.2011.1. Epub 2011 Mar 1.
4
Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary thyroid carcinoma.甲状腺微小乳头状癌与甲状腺乳头状癌基因表达谱的比较分析
J Cancer Res Ther. 2010 Oct-Dec;6(4):452-7. doi: 10.4103/0973-1482.77103.
5
Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population.对甲状腺髓样癌患者 RET 原癌基因关键外显子的分子分析：对伊朗人群的综合研究。
Thyroid. 2011 Apr;21(4):373-82. doi: 10.1089/thy.2010.0267.
6
Follicular nodules (THY3) of the thyroid: we recommend surgery.甲状腺滤泡结节（THY3）：我们建议手术。
J Endocrinol Invest. 2011 Jul-Aug;34(7):e183-7. doi: 10.3275/7416. Epub 2010 Dec 15.
7
Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry.利用监测、流行病学和最终结果国家癌症数据库分析甲状腺癌发病率的上升。
Surgery. 2010 Dec;148(6):1147-52; discussion 1152-3. doi: 10.1016/j.surg.2010.10.016.
8
Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells.LRP1B 的染色体、表观遗传和 microRNA 介导失活，是甲状腺癌细胞细胞外环境的调节剂。
Oncogene. 2011 Mar 17;30(11):1302-17. doi: 10.1038/onc.2010.512. Epub 2010 Nov 8.
9
Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas.识别和优化极低危甲状腺微小乳头状癌患者的术后随访。
J Clin Endocrinol Metab. 2010 Nov;95(11):4882-8. doi: 10.1210/jc.2010-0762. Epub 2010 Jul 21.
10
Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups.国家癌症研究所监测、流行病学和最终结果种族/民族群体中的甲状腺癌发病率和生存率。
Thyroid. 2010 May;20(5):465-73. doi: 10.1089/thy.2008.0281.